With the medical industry being characterized by reformative practices, using a wide range of the latest technologies, and revising its reimbursement policies in order to boost health outcomes and enhance patient care, the health care remote monitoring market is likely to have a huge influence on the growth as well as strength of the overall industry.
New tools and devices such as mobile health technologies and biosensors could potentially strengthen and change the health care remote monitoring market. In a news release, the Mayo Clinic announced that the organization is teaming up with Gentag, Inc. in order to develop wearable biosensors that could possibly help weight loss among the obese population and assist in treating diabetes.
James Levine M.D., PhD, an obesity researcher and endocrinologist at Mayo Clinic said in the release that the organization is hoping for this technology to have a huge impact. The patch biosensors could help in reducing the prevalence of diabetes and obesity. James added that the biosensors can be integrated into the way people receive care and are inexpensive as well as accurate.
The wearable devices are in the form of a small bandage or a patch, can be disposed after each use, and work wirelessly. This biosensor patch is essentially a kind of management system for diabetics, which allows them to communicate as well as send data to smart phones.
The more important part is that this device helps in health care remote monitoring as doctors will be able to keep a track of diabetes symptoms and obesity results even when the patients are at their homes and the physicians are in the clinic or hospital.
This tool has been developed by Mayo Clinic and Gentag via a joint intellectual property venture. Both the organizations will be striving to create the next generation wearable biosensors that will have a huge impact on the management as well as treatment of obesity and diabetes.